Cargando…

Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders worldwide and had no approved pharmacological treatments. Diwuyanggan prescription (DWYG) is a traditional Chinese medicine preparation composed of 5 kinds of herbs, which has been used for treating chronic l...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jinlin, Jin, Yuehui, Song, Chengwu, Chen, Guangya, Li, Qiaoyu, Yuan, Hao, Wei, Sha, Yang, Min, Li, Sen, Jin, Shuna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692813/
https://www.ncbi.nlm.nih.gov/pubmed/38045182
http://dx.doi.org/10.1016/j.heliyon.2023.e22151
_version_ 1785153023997116416
author Xu, Jinlin
Jin, Yuehui
Song, Chengwu
Chen, Guangya
Li, Qiaoyu
Yuan, Hao
Wei, Sha
Yang, Min
Li, Sen
Jin, Shuna
author_facet Xu, Jinlin
Jin, Yuehui
Song, Chengwu
Chen, Guangya
Li, Qiaoyu
Yuan, Hao
Wei, Sha
Yang, Min
Li, Sen
Jin, Shuna
author_sort Xu, Jinlin
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders worldwide and had no approved pharmacological treatments. Diwuyanggan prescription (DWYG) is a traditional Chinese medicine preparation composed of 5 kinds of herbs, which has been used for treating chronic liver diseases in clinic. Whereas, the synergistic mechanism of this prescription for anti-NAFLD remains unclear. In this study, we aimed to demonstrate the synergetic effect of DWYG by using the disassembled prescriptions and untargeted metabolomics research strategies. The therapeutic effects of the whole prescription of DWYG and the individual herb were divided into six groups according to the strategy of disassembled prescriptions, including DWYG, Artemisia capillaris Thunb. (AC), Curcuma longa L. (CL), Schisandra chinensis Baill. (SC), Rehmannia glutinosa Libosch. (RG) and Glycyrrhiza uralensis Fisch. (GU) groups. The high fat diets-induced NAFLD mice model was constructed to evaluate the efficacy effects of DWYG. An untargeted metabolomics based on the UPLC-QTOF-MS/MS approach was carried out to make clear the synergetic effect on the regulation of metabolites dissecting the united mechanisms. Experimental results on animals revealed that the anti-NAFLD effect of DWYG prescription was better than the individual herb group in reducing liver lipid deposition and restoring the abnormality of lipidemia. In addition, further metabolomics analysis indicated that 23 differential metabolites associated with the progression of NAFLD were identified and 19 of them could be improved by DWYG. Compared with five single herbs, DWYG showed the most extensive regulatory effects on metabolites and their related pathways, which were related to lipid and amino acid metabolisms. Besides, each individual herb in DWYG was found to show different degrees of regulatory effects on NAFLD and metabolic pathways. SC and CL possessed the highest relationship in the regulation of NAFLD. Altogether, these results provided an insight into the synergetic mechanisms of DWYG from the metabolic perspective, and also supported a scientific basis for the rationality of clinical use of this prescription.
format Online
Article
Text
id pubmed-10692813
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106928132023-12-03 Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics Xu, Jinlin Jin, Yuehui Song, Chengwu Chen, Guangya Li, Qiaoyu Yuan, Hao Wei, Sha Yang, Min Li, Sen Jin, Shuna Heliyon Research Article Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders worldwide and had no approved pharmacological treatments. Diwuyanggan prescription (DWYG) is a traditional Chinese medicine preparation composed of 5 kinds of herbs, which has been used for treating chronic liver diseases in clinic. Whereas, the synergistic mechanism of this prescription for anti-NAFLD remains unclear. In this study, we aimed to demonstrate the synergetic effect of DWYG by using the disassembled prescriptions and untargeted metabolomics research strategies. The therapeutic effects of the whole prescription of DWYG and the individual herb were divided into six groups according to the strategy of disassembled prescriptions, including DWYG, Artemisia capillaris Thunb. (AC), Curcuma longa L. (CL), Schisandra chinensis Baill. (SC), Rehmannia glutinosa Libosch. (RG) and Glycyrrhiza uralensis Fisch. (GU) groups. The high fat diets-induced NAFLD mice model was constructed to evaluate the efficacy effects of DWYG. An untargeted metabolomics based on the UPLC-QTOF-MS/MS approach was carried out to make clear the synergetic effect on the regulation of metabolites dissecting the united mechanisms. Experimental results on animals revealed that the anti-NAFLD effect of DWYG prescription was better than the individual herb group in reducing liver lipid deposition and restoring the abnormality of lipidemia. In addition, further metabolomics analysis indicated that 23 differential metabolites associated with the progression of NAFLD were identified and 19 of them could be improved by DWYG. Compared with five single herbs, DWYG showed the most extensive regulatory effects on metabolites and their related pathways, which were related to lipid and amino acid metabolisms. Besides, each individual herb in DWYG was found to show different degrees of regulatory effects on NAFLD and metabolic pathways. SC and CL possessed the highest relationship in the regulation of NAFLD. Altogether, these results provided an insight into the synergetic mechanisms of DWYG from the metabolic perspective, and also supported a scientific basis for the rationality of clinical use of this prescription. Elsevier 2023-11-10 /pmc/articles/PMC10692813/ /pubmed/38045182 http://dx.doi.org/10.1016/j.heliyon.2023.e22151 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Xu, Jinlin
Jin, Yuehui
Song, Chengwu
Chen, Guangya
Li, Qiaoyu
Yuan, Hao
Wei, Sha
Yang, Min
Li, Sen
Jin, Shuna
Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics
title Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics
title_full Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics
title_fullStr Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics
title_full_unstemmed Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics
title_short Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics
title_sort comparative analysis of the synergetic effects of diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692813/
https://www.ncbi.nlm.nih.gov/pubmed/38045182
http://dx.doi.org/10.1016/j.heliyon.2023.e22151
work_keys_str_mv AT xujinlin comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT jinyuehui comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT songchengwu comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT chenguangya comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT liqiaoyu comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT yuanhao comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT weisha comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT yangmin comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT lisen comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics
AT jinshuna comparativeanalysisofthesynergeticeffectsofdiwuyangganprescriptiononhighfatdietinducednonalcoholicfattyliverdiseaseusinguntargetedmetabolomics